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Biomimetic PEG hydrogels crosslinked with minimal
plasmin-sensitive tri-amino acid peptides
Abstract
Semi-synthetic, proteolytically degradable polymer hydrogels have proven effective as scaffolds to
augment bone and skin regeneration in animals. However, high costs due to expensive peptide building
blocks pose a significant hurdle towards broad clinical usage of these materials. Here we demonstrate
that tri-amino acid peptides bearing lysine (or arginine), flanked by two cysteine residues for
crosslinking, are adequate as minimal plasmin-sensitive peptides in poly(ethylene glycol)-based
hydrogels formed via Michael-type addition. Substitution of lysine (or arginine) with serine rendered the
matrices insensitive to the action of plasmin. This was demonstrated in vitro by performing gel
degradation experiments in the presence of plasmin (0.1 U/mL), and in the in vivo situation of
regeneration of critical-sized bone defects. When placed as implants into rat calvaria, gels formed from
the minimal plasmin substrates showed clear signs of cell infiltration and gel remodeling that coincided
with extensive bone formation. (c) 2009 Wiley Periodicals, Inc. J Biomed Mater Res, 2009.
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ABSTRACT  
Semi-synthetic, proteolytically degradable polymer hydrogels have proven effective as scaffolds 
to augment bone and skin regeneration in animals. However, high costs due to expensive peptide 
building blocks pose a significant hurdle towards broad clinical usage of these materials. Here 
we demonstrate that tri-amino acid peptides bearing lysine (or arginine), flanked by two cysteine 
residues for crosslinking, are adequate as minimal plasmin-sensitive peptides in poly(ethylene 
glycol)-based hydrogels formed via Michael-type addition. Substitution of lysine (or arginine) 
with serine rendered the matrices insensitive to the action of plasmin. This was demonstrated in 
vitro by performing gel degradation experiments in the presence of plasmin (0.1 U/mL), and in 
the in vivo situation of regeneration of critical-sized bone defects. When placed as implants into 
rat calvaria, gels formed from the minimal plasmin substrates showed clear signs of cell 
infiltration and gel remodelling that coincided with extensive bone formation.   
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1. INTRODUCTION 
 
Tissue regeneration typically starts with the formation of a fibrin hydrogel, polymerized in a 
wound immediately after injury to stop bleeding, that serves as temporary cellular scaffold for 
cell infiltration into the wound from the surrounding tissue [1,2]. The fibrin matrix is 
subsequently degraded and replaced by a newly formed tissue-specific extracellular matrix 
network. Cell-secreted and -activated proteases such as matrix metalloproteases (MMPs) and the 
serine protease plasmin are the key effectors in this localized fibrin breakdown. They enable 
inflammatory and tissue-specific cells to populate the clot and to initiate fibrin remodeling [3].  
Emerging biomaterials approaches to tissue regeneration have focused on mimicking 
fibrin to form biomaterials in situ, at the site of a tissue defect, acting as degradable scaffolds to 
stimulate the regeneration process [4,5]. The complexity and wide range of targeted clinical 
applications for such biomaterials necessitates flexible design strategies. The scaffold should 
have biological and physicochemical characteristics that are tunable towards specific medical 
needs and particular tissues. Engineered biomaterials should overcome some of the limitations of 
‘classical’, state-of-the-art regeneration matrices such as collagen or fibrin itself. Although these 
biopolymer networks possess outstanding biological characteristics, their inherent properties 
such as degradation kinetics are difficult to adapt to specific applications.  
Some of us had previously engineered key biochemical characteristics of naturally 
derived matrices into synthetic, poly(ethylene glycol) (PEG) hydrogel networks [6-12]. 
Accordingly, hydrogels equipped with peptides to facilitate cell adhesion and susceptibility to 
degradation by either MMPs [8-10,13,14], plasmin [7,11] or to both proteases [12], enable 
proteolytic cell migration in 3-dimensions, a rather complex physiological process.  Moreover, in 
the presence of potent tissue-inducing biomolecules such as bone morphogenetic protein-2 
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(BMP-2) [8,10-12] or vascular endothelial growth factor (VEGF) [5,9,15], these hydrogels 
stimulated extensive bone regeneration and angiogenesis, respectively. The above studies also 
underscored the importance of designing matrix proteolytic sensitivity, as in the absence of this 
functionality the lack of cell infiltration and matrix remodeling led to significantly reduced tissue 
regeneration. 
While synthetic biomimetic hydrogels can perform surprisingly well in a biological 
environment, augmenting bone regeneration or stimulating angiogenesis, they suffer from 
relatively high production costs compared to biologically derived scaffolds. Oligopeptide gel 
components represent the main cost factor for this class of materials, with costs increasing nearly 
proportional to the peptide length. The high costs can present a limitation to wide-range clinical 
application.  
To reduce peptide length and thus costs of synthetic biomimetic hydrogels, the main goal 
of this study was to explore materials designs with minimal peptide length of the proteolytically-
sensitive linker peptide.  We focused on plasmin-degradable peptides due the relevance of 
plasmin in proteolytic remodeling of fibrin [1] and our previous findings with relatively short 
plasmin substrates as hydrogel components [11]. We found that hydrogels formed with the tri-
amino acid peptides bearing either lysine or arginine, but not serine residues, are susceptible to 
plasmin degradation both in vitro and in vivo. 
 
2. EXPERIMENTAL 
2.1. Materials 
Ac-CKC-NH2 (CKC, Mw: 394 Da, net peptide content: 70.6%), Ac-CRC-NH2 (CRC, Mw: 422 
Da, net peptide content: 73.8%), and Ac-CSC-NH2 (CSC, Mw: 353 Da, net peptide content was 
not provided and was assumed to be 100%) were purchased from Neosystems (Strasbourg, 
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France). These peptides were designed containing single amino acids flanked only by cysteines 
to allow the peptides to undergo crosslinking with branched, vinylsulfone (VS)-terminated PEGs 
to form hydrogels via Michael-type addition. Peptide purity was 95-96% as determined by 
HPLC analysis. Peptide Ac-GCYKNRDCG-NH2 (C2KR, Mw: 1056 Da;  marks cleavage 
sites) was synthesized and purified as reported earlier [11]. 4-arm PEG-OH (Mw: 20 kDa) was 
purchased from Nektar (Huntsville, USA) and functionalized with vinyl sulfone groups PEG (4-
arm PEG-VS) as described earlier [16,17]. The degree of end-group conversion as ssessed by 1H 
NMR (400.13MHz, CDCl3) was shown to be 81%:  6.87-6.78 (dd, CH=CH2), 6.43-6.36 (d, 
CH=CH2), 6.10-6.06 (d, CH=CH2), 3.69-3.61 (s, CH2CH2O). 
 
2.2. Rheometry and equilibrium swelling (Qm) 
Rheological experiments were performed with a Bohlin CVO 120 high-resolution rheometer 
with plate-plate geometry at 25 °C as described previously [16]. Qm was defined as the ratio of 
the mass of swollen gel to the mass of dried gel.  
 
2.3. Hydrogel formation 
Hydrogels were formed at 20% (w/v) via Michael-type conjugate addition of peptide thiols 
(Scheme 1 and 2) onto vinyl sulfones of end-functionalized 4-arm PEG-VS in 0.3 M of 
triethanolamine (TEOA) buffer at pH 7.6, employing previously published methods [16,17].  
Briefly, to form 25 L hydrogels containing 20% (w/v) polymer, precursor solutions were mixed 
at various stoichiometry ratios r = [SH]/[VS] (SH, cysteine thiols; VS, vinyl sulfone groups on 
PEG termini) and formed as discs between two Sigma-coated (Sigamacote®, Sigma-Aldrich, 
Germany) glass slides separated by 0.8 mm thick spacers. Crosslinking was allowed to proceed 
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for 30 minutes at 37 C in a humidified atmosphere, and the gels were swollen overnight in 0.1 
M phosphate buffered saline (PBS) (pH 7.4).   
 
 
Scheme 1. Designed tri-amino acid peptides (top). The plasmin-sensitive peptide C2KR 
(bottom) was selected as a positive control based on earlier work [11]. 
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Scheme 2. PEG-co-peptide hydrogel formation by Michael-type addition. 
 
2.4. Hydrogel degradation  
Hydrogel discs (25 L) were incubated in a solution of 4 mL PBS containing 0.1 U/mL bovine 
plasmin (Roche, Switzerland). Samples were weighted at different time points. Each condition 
was measured in triplicate.  
 
2.5. Preparation of hydrogel disks for animal experiments 
In order to facilitate cell invasion into non-adhesive hydrogels, gel formulations described above 
(see 2.3) were augmented to covalently attach the integrin-binding peptide Ac-
GCGYGRGDSPG-NH2 to the gel network following published protocols [10]. Moreover, 5 g 
rhBMP-2 was physically entrapped into gels by mixing it with the PEG precursor before gelation 
according to published methods [10].  
 
2.6. Animal experimentation  
Animal experiments were authorized by the Veterinary Authority of the Canton of Zurich. Adult 
female Sprague-Dawley albino rats (300–350 g) were used and bone regeneration experiments 
were conducted exactly according to published methods [10,11]. Explants were sequentially 
dried, defatted, fixed, and embedded. Sections were stained with Toluidine blue O and Goldner 
Trichrome. Three animals were used per gel type. 
 
3. RESULTS AND DISCUSSION 
3.1. Design of minimal putative plasmin substrate peptides 
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West and Hubbell had previously synthesized PEG-based gels from telechelic macromers 
modified by the plasmin-sensitive oligopeptide Val-Arg-Asn (VRN,  denotes proteolytic 
cleavage site), derived from the -chain of fibrinogen. This peptide was found to be cleavable by 
plasmin proteolysis, yet insensitive to the action of other proteolytic enzymes, such as matrix 
metalloproteinases (MMPs) or elastase [6]. In later generations of PEG-based plasmin-sensitive 
hydrogels some of us employed either single or multiple fibrinogen-derived plasmin substrates 
within a given peptide, Ac-GCYKNRDCGYKNRCG-NH2 [11], or recombinant protein 
polymer, -(…NNRDNTYNRVSEDL…)n- [7], -(...NNRDNTY…)n- [17]. Interestingly, in 
the latter study biochemical investigations revealed the presence of unexpected plasmin cleavage 
sites in negative control constructs,  -(...NNGDNTY…)n-  [17]. N-terminal sequencing of 
plasmin-degraded products indicated that the C-terminus of arginine residues in the proteins 
might act as substrates for plasmin [17]. Indeed, arginines and lysines typically mark cleavage 
sites in proteins [18] and are commonly known P1 sites (i.e. amino acids adjacent to the C-
terminus of the proteolytic cleavage site).  Oftentimes, arginine cleavage sites are flanked by 
amino acids with aromatic side groups such as tyrosine or tryptophan [19,20]. Based on these 
findings we hypothesized that isolated lysine or arginine residues might be sufficient to act as 
substrates for plasmin in PEG-based hydrogels.  In order to test this hypothesis, we designed 
peptides containing single amino acids flanked only by cysteines (cysteine-lysine-cysteine, CKC, 
and cysteine-arginine-cysteine, CRC, see Scheme 1). This peptide design allowed the peptides to 
undergo crosslinking with branched, vinylsulfone (VS)-terminated PEGs to form hydrogels via 
Michael-type addition (Scheme 2). As potential negative control peptide, the amino acid serine 
was flanked by cysteines.  
3.2. Hydrogel formation and characterization 
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We next tried to form solid hydrogels via Michael-type addition (Scheme 2) by mixing two 
liquid precursors containing 4-arm PEG-VS and each of the above Cys-containing tri-amino acid 
peptides (Scheme 1). Indeed, at pH 7.6 we were able to form hydrogels within ca. 10 minutes 
after mixing of relatively highly concentrated aqueous precursors. Remarkably, compared to our 
previous PEG-co-peptide gel system [16], in which networks were formed at precursor 
concentrations as low as 5% (note: same PEG macromers were used but 16-amino acid-long 
peptides), gel crosslinked with very small peptides only formed reliably at concentrations above 
15%.  In order to determine the ratio of functional groups that would lead to nearly ideal gel 
networks [16,17], the equilibrium swelling ratio Qm and elastic modulus G’ of swollen gels were 
determined as a function of r = [SH]/[VS]. A minimal Qm and maximum in G’ at ropt was found 
at slightly excessive amounts of SH-groups for CKC (ropt = 1.1) and CRC (1.15), respectively, 
and r = 0.9 for CSC. 
 
Figure 1. Equilibrium swelling (Qm) of hydrogels formed from 4-arm PEG-VS and tri-amino 
acid linker peptide at different stoichiometric ratios r = [SH]/[VS]. (Error bars: Standard error of 
the mean, n = 3) 
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Figure 2. Elastic shear modulus (G’) of hydrogels formed from 4-arm PEG-VS and tri-amino 
acid linker peptide at different stoichiometric ratios r = [SH]/[VS]. (Error bars: Standard error of 
the mean, n = 3) 
 
The slight excess of thiols that was required to obtain optimal physicochemical properties in 
CKC and CRC gels can most likely be attributed to the SH-consumption via disulfide bond (-S-
S-) formation, that may occur concurrently with the Michael-type addition [16,17]. The rather 
unexpected ropt of hydrogels cross-linked with CSC (r < 1) may be explained by a different 
reactivity of thiols to form either covalent bonds with vinylsulfone or disulfide bonds due to 
differences in thiol pKa’s [21].  This is to say, we had previously demonstrated that the pKa of 
the sulfhydryl groups of cysteines is highly dependent on adjacent charged amino acids, 
positively charged amino acids lowering the pKa and negatively charged amino acids having the 
opposite effect. Since deprotonated thiols are the reactive species in the conjugate addition 
reaction, lysine and arginine render thiols in CKC and CRC more reactive than serine in CSC.  
 
3.3. Hydrogel degradation characteristics 
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Figure 3. Degradation of hydrogels in PBS containing 0.1 U/mL plasmin at 37 °C monitored for 
30 h (a) and 130 h (b). (Error bars: Standard error of the mean, n = 3) 
To investigate the proteolytic degradation kinetics upon exposure to plasmin, hydrogels 
with different linker types but equivalent swelling ratios and elastic moduli (r = 0.85 for CSC, 
1.1 for CKC, and 1.15 for CRC, respectively) were selected and swelling and weight loss 
determined as a function of incubation time (Fig. 3). As expected, gels containing the plasmin-
sensitive control peptides C2KR showed the fastest degradation, primarily mediated by surface 
erosion (i.e. no increase in gel weight during dissolution). Complete gel dissolution occurred 
after ca. 5 h of incubation, consistent with previous findings [11] (Fig. 3a). In marked contrast, 
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no weight change and thus degradation was observed during the 6-day test period in gels 
containing the control peptide CSC.  
CKC- and CRC-containing hydrogels exhibited sensitivity to plasmin degradation (Fig. 
3a and b). CKC-bearing gels degraded significantly faster than those crosslinked with CRC (ca. 
130 h vs. ca. 240 h for complete gel dissolution, respectively). We also noted that CKC- and 
CRC-gels initially increased in weight during degradation, suggesting a predominant bulk 
degradation mechanism, in contrast to C2KR-containing control gels that appeared to primarily 
degrade via surface erosion. Notably, the peptide VRN (Val-Arg-Asn) that was introduced in 
earlier work as plasmin-sensitive substrate within photopolymerized PEG-based hydrogels, 
showed slower degradation kinetics (400 h at 2 U/mL plasmin; 600 h at 0.2 U/mL) [6] compared 
to gels made with CKC-peptide (130 h at 0.1 U/mL plasmin).  Therefore, these results clearly 
demonstrate that arginine or lysine alone, when flanked by reactive cysteines, can serve as 
effective plasmin substrates in crosslinked PEG-based hydrogels. However, it should also be 
noted that other proteolytic enzymes, such as MMPs, may cleave these peptides.  
Proteolytic enzymes usually bind to substrates comprised of several amino acids. Various 
methodologies, ranging from classical amino acid sequence studies [22] to positional scanning 
libraries of fluorogenic peptides [19] and microarray techniques [20], have been used to uncover 
the primary peptide structure of fibrinogen plasmin substrates. Specificity is primarily 
determined by the amino acid in P1 position. In some substrates, the P1 residue and the 
following P1’ amino acid will contribute to interactions that define the cleavage site [23]. It is 
widely accepted that substrates with lysine at P1 are degraded faster than with arginine in that 
position [19,20,24], which is in agreement with our results. From structural analyses of the 
human fibrinogen -chain, several amino acids including methionine, serine or alanine were 
identified as P1’ sites [22], although it is still poorly understood which P1’ amino acid induces 
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the fastest degradation [25]. Moreover, the active site of plasmin fits best in a substrate ‘pocket’ 
that contains tyrosine or tryptophan at P2 [19]. The C2KR peptide fits these criteria and shows 
significantly faster degradation compared to CKC or CRC. To the best of our knowledge, 
polymer-conjugated cysteines were not previously reported as P1’ and P2 sites. Our results show 
that cysteines, with their thiols bound to vinylsulfones via thioether bonds, can act as P1’ and P2 
site, as plasmin degradability of gels bearing Cys-containing tri-amino acid peptide is retained. 
 
3.4. In vivo enzymatic degradation: induction of bone regeneration 
To test the susceptibility to degradation of the newly designed plasmin-sensitive gels in a 
relevant in vivo scenario, we utilized the previously established rat calvarial bone defect model 
[26]. This model is frequently used to test the suitability of bioactive molecules, such as bone 
morphogenetic proteins (BMP), and scaffolds to induce regeneration of large bone defects and 
our group had used it successfully in the development of plasmin-sensitive gels [11]. We 
fabricated gel disks (8 mm diameter) containing non-covalently entrapped BMP-2, implanted the 
samples in critical size defects of the same diameter in rats, and sacrificed animals after 3 wk to 
analyze via histology the response of the materials to its in vivo environment. Histology 
demonstrated a highly materials-dependent cellular infiltration and bone-healing outcome (Fig. 
4).  
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Figure 4. Histological analyses of cell infiltration and bone healing. Cross-sections of defects 3 
weeks after gel implantation. Representative sections of implants of 3 animals are shown for 
each gel type.  
Non-degradable CSC-type gels showed a sharp interface between the still intact hydrogel and the 
surrounding tissue (Fig. 4, top row; note that the mineralized phase shows up in green). 
Apparently, the presence of 5 g BMP-2 per implant led to bone formation around the plasmin-
insensitive implants. The smooth surface of the gel phase indicated that no cell infiltration took 
place. Therefore, the non-degradable and relatively dense gel matrix acted as a physical barrier 
for surrounding cells. Qualitatively, plasmin-degradable gels showed a markedly different 
outcome. The tissue-gel interface of most explants was not smooth but rather irregularly shaped, 
showing signs of extensive infiltration by host cells (Fig. 4).  
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Figure 5. Histological analyses of cell infiltration at higher magnification. Cross-sections of 
defects 3 weeks after gel implantation. Representative sections of one implant are shown for 
each gel type. The small black and red squares in the complete cross-sections correspond to the 
higher magnification shown in the middle and right columns, respectively.  (Scale bars = 200m)  
As is evident at higher magnification (Fig. 5), these irregularities were created by local, cell-
mediated gel breakdown, consistent with earlier findings [11]. In some implants the plasmin 
degradation of hydrogels enabled a more pronounced de novo bone formation through gel 
remodeling, compared to the non-degradable control. Surprisingly, the most extensive gel 
degradation was observed in CRC gels and not in C2KR gels that in vitro showed the fastest 
 16
degradation (Fig. 3). The apparent contradiction between in vivo and in vitro data may be 
attributed to the fact that in a complex in vivo regeneration microenvironment many types of 
proteases can be found and therefore, even though the peptides were designed as plasmin 
substrates, other proteases such as MMPs could be responsible for the in vivo gel degradation. 
Moreover, due to the variability among animals of even the same gel type, which may be 
attributed for example to differences in mechanical properties but also differential BMP2-
retention (previously shown to be ca. 90% in PEG-based gels [10]), larger sample numbers and a 
quantification of healing are crucial to substantiate the above observation.  
In an earlier study of gels composed of the same plasmin substrate YKNRD as in the present 
C2KR gels, a more extensive cell infiltration was observed at 3 wk and the same dose of BMP-2 
[11].  In some regions the entire thickness of implants was replaced by cellular processes. This 
discrepancy may be explained by the fact that the previous gels were composed of a different 
molecular architecture (peptides containing three cysteines crosslinked with linear PEG-
vinylsulfones) that led to a less densely crosslinked network, which could have resulted in a 
more rapid degradation of implants. Nevertheless, our experiments revealed that minimal 
plasmin substrates as gel components can be degraded via endogenous mechanisms in an in vivo 
context, and that this characteristic can be explored to regenerate large bone defects in a critical 
size defect model. Longer implantation times will reveal whether these novel gels are completely 
remodeled by natural mineralized tissue. 
 
4. CONCLUSIONS 
We show that tri-amino acid peptides bearing lysine or arginine, flanked by cysteines, can serve 
as key functional components of plasmin-degradable PEG hydrogels. Substitution of lysine or 
arginine with serine residues rendered the hydrogels insensitive to plasmin. Despite of the slower 
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in vitro gel degradation rate compared to gels with longer, naturally derived plasmin substrates 
(C2KR), in an in vivo context of bone regeneration, the maximally truncated substrates 
performed similarly well. The modularity to incorporate desired biomolecules of the present 
hybrid hydrogels, together with their significantly lower costs, promises to render these materials 
attractive for clinical applications.  
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